Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q2 2023 · 10-Q
Revenue—
Net Income-$1.67M-$1.67MN/M vs Q2 2022 EPS Diluted-$0.02-$0.02N/M vs Q2 2022 Operating Income-$1,486,492N/M Operating Cash Flowderived-$903,895N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Jan 31, 2023 · filed Mar 17, 2023 · 45 d after period end